Group 1: Company Overview and Core Business - Beijing BWS Technology Co., Ltd. specializes in environmental protection and water treatment, with a comprehensive layout in the water treatment industry [2] - The company has developed core advantages in membrane material research, equipment manufacturing, and digital water management, holding proprietary technologies in microfiltration, ultrafiltration, nanofiltration, and reverse osmosis [2] - BWS operates advanced membrane production bases in Beijing and Tianjin, with a capacity of 20 million square meters for microfiltration/ultrafiltration membranes and 19 million square meters for nanofiltration/reverse osmosis membranes annually [2] Group 2: Strategic Development and Business Focus - The company is implementing the "12256" strategy to enhance operational quality and efficiency, focusing on high-value-added business segments [3] - BWS aims to transition from "large investment, large projects, large growth" to "high innovation, high intelligence, high environmental quality" [3] - The company is expanding into high-value sectors such as industrial water treatment, seawater resource utilization, and lithium extraction from salt lakes [3] Group 3: Recent Project Developments - In the industrial wastewater treatment sector, BWS has secured projects in Northeast China, including a 1.52 billion yuan project in Liaoning with a 40-year concession period [3] - The company also won a 1.98 billion yuan total contracting project in Liaoyuan, focusing on pharmaceutical and chemical enterprises [3] - A project in Shandong for upgrading and expanding capacity was valued at 66.9 million yuan, aimed at better water resource utilization [3] Group 4: Innovations in Health Sector - BWS is developing a pharmaceutical membrane business, focusing on protein separation and virus removal, aligning with national bio-economy strategies [4] - The company has formed a dedicated team for biopharmaceutical membrane development, achieving breakthroughs in four product categories, including ATF perfusion series and virus removal membranes [4] Group 5: Financial Management and Accounts Receivable - BWS is addressing pressures from accounts receivable, a legacy of previous expansive growth, and is implementing measures to improve collection [5] - The company has established a special team for debt recovery and is actively participating in local government debt resolution efforts [5] - Recent measures have shown gradual improvement in accounts receivable recovery [5]
碧水源(300070) - 2025年11月27日投资者关系活动记录表